MX2009005066A - Composiciones para mejorar la condicion y apariencia de la piel y metodos para su uso. - Google Patents

Composiciones para mejorar la condicion y apariencia de la piel y metodos para su uso.

Info

Publication number
MX2009005066A
MX2009005066A MX2009005066A MX2009005066A MX2009005066A MX 2009005066 A MX2009005066 A MX 2009005066A MX 2009005066 A MX2009005066 A MX 2009005066A MX 2009005066 A MX2009005066 A MX 2009005066A MX 2009005066 A MX2009005066 A MX 2009005066A
Authority
MX
Mexico
Prior art keywords
skin
compositions
improving
condition
methods
Prior art date
Application number
MX2009005066A
Other languages
English (en)
Inventor
Laurence Dryer
Dmitri S Ptchelintsev
Sherrie R Tafuri
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of MX2009005066A publication Critical patent/MX2009005066A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El presente invento se relaciona con composiciones y métodos para el tratamiento, prevención y mejora de la condición y apariencia estética de la piel, particularmente, el tratamiento, prevención, mejoramiento, reducción y/o eliminación de las líneas finas y/o las arrugas de la piel, donde las composiciones incluyen constituyentes naturales de plantas o sus equivalentes sintéticos, los cuales inhiben o disminuyen la expresión, producción o secreción de la proteína C-reactiva, reduciendo, inhibiendo o mejorando de ese modo las señales dermatológicas del envejecimiento. Las composiciones del invento se pueden aplicar tópicamente a la piel, o se suministran por medios dirigidos al sitio que los requiera, en una cantidad efectiva para el mejoramiento de la condición y apariencia estética de la piel.
MX2009005066A 2006-12-29 2007-10-10 Composiciones para mejorar la condicion y apariencia de la piel y metodos para su uso. MX2009005066A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/647,648 US7642062B2 (en) 2006-12-29 2006-12-29 Compositions and methods of their use for improving the condition and appearance of skin
PCT/US2007/080940 WO2008082736A2 (en) 2006-12-29 2007-10-10 Compositions and methods of their use for improving the condition and appearance of skin

Publications (1)

Publication Number Publication Date
MX2009005066A true MX2009005066A (es) 2009-05-25

Family

ID=39584317

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005066A MX2009005066A (es) 2006-12-29 2007-10-10 Composiciones para mejorar la condicion y apariencia de la piel y metodos para su uso.

Country Status (10)

Country Link
US (2) US7642062B2 (es)
EP (1) EP2117505A2 (es)
JP (1) JP2010514774A (es)
CN (1) CN101573101A (es)
AR (1) AR063862A1 (es)
BR (1) BRPI0718885A2 (es)
CA (1) CA2674226A1 (es)
MX (1) MX2009005066A (es)
TW (1) TW200826971A (es)
WO (1) WO2008082736A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
JP2010524959A (ja) * 2007-04-17 2010-07-22 コドマン・アンド・シャートレフ・インコーポレイテッド アルツハイマー病を処置するためのヘリウムガスボーラス中のクルクミンの鼻腔投与
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US7985776B2 (en) 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
US7723515B1 (en) 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
KR101223749B1 (ko) * 2009-11-20 2013-01-17 재단법인 제주테크노파크 율초 또는 붉가시나무 잎 추출물을 이용한 아토피 피부염 개선제 조성물
CN106727054A (zh) * 2010-06-30 2017-05-31 雅芳产品公司 用于刺激magp‑1以改善皮肤外观的组合物和方法
US8658227B2 (en) * 2011-03-02 2014-02-25 Leslie Marie Radentz Botanical formulation derived from birch bark
KR101523812B1 (ko) * 2012-03-07 2015-05-28 손원록 율초 추출물을 유효성분으로 함유하는 대사성 질환 예방 및 치료용 조성물
JP6823938B2 (ja) * 2016-03-30 2021-02-03 株式会社アイビー化粧品 皮膚外用剤
KR102194073B1 (ko) * 2018-12-06 2020-12-22 농업회사법인제주생물자원(주) 하귤 오일을 포함하는 피부 노화 억제 및 피부 보습용 기능성 화장료 조성물
FR3097559B1 (fr) * 2019-06-24 2021-06-25 Oreal Méthode de diagnostic de dégradations esthétiques de la peau

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US596842A (en) * 1898-01-04 Waterproof material
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4820724A (en) 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
US5223262A (en) 1989-02-23 1993-06-29 University Of Utah Transdermal delivery system utilizing one way membranes
US4956171A (en) 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5146846A (en) 1990-05-01 1992-09-15 F. H. Maloney Company Roller assembly for grain shellers
US5834513A (en) 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5847003A (en) 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
JPH1072336A (ja) * 1996-06-28 1998-03-17 Kao Corp コラーゲンゲル収縮促進剤
JP4915714B2 (ja) * 1996-06-28 2012-04-11 花王株式会社 コラーゲンゲル収縮促進剤
JPH1036279A (ja) * 1996-07-18 1998-02-10 Ichimaru Pharcos Co Ltd 植物抽出物含有線維芽細胞増殖促進剤
EP0872447B1 (en) * 1996-09-30 2011-07-13 Shiseido Company, Ltd. Silicon oxide powder and process for the production thereof, cosmetics made by using the same, micelle-retaining powder, and perfume-retaining powder
US6726933B2 (en) * 1996-09-30 2004-04-27 Shiseido Co., Ltd. Rod-shaped mesoporous powder, humectant adsorbing powder, and cosmetic preparation using the same
JP3436037B2 (ja) * 1997-01-10 2003-08-11 株式会社豊田中央研究所 バルク状シリカ多孔体の製造方法
JPH11246336A (ja) * 1998-02-27 1999-09-14 Ichimaru Pharcos Co Ltd 活性酸素消去剤及び美肌化粧料組成物
JPH11246387A (ja) * 1998-03-03 1999-09-14 Shiseido Co Ltd 抗老化剤
US6096327A (en) 1998-11-05 2000-08-01 Protease Sciences Inc. Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
JP2000247830A (ja) * 1999-02-26 2000-09-12 Nagase & Co Ltd エラスターゼ阻害剤
US6056545A (en) * 1999-04-20 2000-05-02 Lemchen; Marc. S. Mesoporous metal for orthodontic appliances
JP4070065B2 (ja) * 1999-07-15 2008-04-02 株式会社資生堂 肌あれ防止・改善用皮膚外用剤
US7736661B1 (en) 2000-03-07 2010-06-15 Avon Products, Inc Method of treating skin conditions
WO2001068804A2 (en) * 2000-03-10 2001-09-20 Lifespan Biosciences, Inc. Nucleic acid sequences associated with aging, particularly skin aging
US6764826B2 (en) 2000-06-08 2004-07-20 Board Of Regents, The University Of Texas System Inhibitors of C-reactive protein induced inflammation
DE10132953A1 (de) 2001-07-06 2003-01-16 Beiersdorf Ag Verwendung von Hopfen-bzw. Hopfen-Malz-Extrakten in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe gegen und Behandlung von degenerativen Hauterscheinungen
AU2003210904A1 (en) * 2002-02-07 2003-09-02 Galileo Lab Inc Cytoprotective benzofuran derivatives
ITMI20020632A1 (it) 2002-03-27 2003-09-29 Indena Spa Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene
US20040213996A1 (en) * 2002-04-30 2004-10-28 National Institute Of Advanced Industrial Science And Technology Mesoporous inorganic materials having controlled-release on-off control function, production method thereof and method using same
US6902806B2 (en) * 2002-04-30 2005-06-07 National Institute Of Advanced Science And Technology Mesoporous silica having controlled-release on-off control function, production method thereof and method using same
ITMI20021692A1 (it) 2002-07-30 2002-10-29 Indena Spa Polisaccaride di echinacea angustifolia.
ITMI20021691A1 (it) 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
US7183057B2 (en) 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
US20050260265A1 (en) * 2004-05-20 2005-11-24 Wyrsta Michael D Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture
US7618662B2 (en) * 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
JP2006327966A (ja) * 2005-05-25 2006-12-07 Pola Chem Ind Inc 皮膚外用剤とその適用
JP2006327967A (ja) * 2005-05-25 2006-12-07 Pola Chem Ind Inc フラボノイドを含有する皮膚外用剤

Also Published As

Publication number Publication date
US20100062086A1 (en) 2010-03-11
BRPI0718885A2 (pt) 2014-02-18
TW200826971A (en) 2008-07-01
CN101573101A (zh) 2009-11-04
EP2117505A2 (en) 2009-11-18
US20080160109A1 (en) 2008-07-03
WO2008082736A3 (en) 2008-10-09
AR063862A1 (es) 2009-02-25
CA2674226A1 (en) 2008-07-10
WO2008082736A2 (en) 2008-07-10
US7642062B2 (en) 2010-01-05
JP2010514774A (ja) 2010-05-06

Similar Documents

Publication Publication Date Title
MX2009005066A (es) Composiciones para mejorar la condicion y apariencia de la piel y metodos para su uso.
WO2006068786A3 (en) Compositions and methods of their use for improving the condition and appearance of skin
EP3272329A3 (en) Compositions and methods for stimulation magp-1 to improve the appearance of skin
WO2006068779A3 (en) Compositions and methods of their use for improving the condition and appearance of skin
MX2010004877A (es) Composiciones cosmeticas de pasos multiples.
WO2009079451A3 (en) Compositions and methods of promoting wound healing
MX2007007376A (es) Uso de extractos de plantas naturales en composiciones cosmeticas.
WO2008079760A3 (en) Nanocomposite pigments in a topical cosmetic application
BRPI0511322A (pt) composições adequadas para o tratamento de sinais cutáneos provenientes do envelhecimento, tablete e formulação de tablete
MY171285A (en) Skin care compositions containing combinations of natural ingredients
MX2011007536A (es) Compuestos beta amino ester y usos de los mismos.
WO2009050506A3 (en) Combination 059
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
MX2012001374A (es) Usos cosmeticos de extractos de levadura estresada modificados y composiciones relacionadas.
WO2012074235A3 (ko) 피부 미백 및 탄력 개선용 화장료 조성물
WO2009125925A3 (ko) 성장인자―미미킹 펩타이드 및 그의 용도
WO2013060771A3 (en) Composition containing an extract of a sequential or simultaneous fermentation
WO2006068778A3 (en) The use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
MX2009002224A (es) Composicion a base de xantoxilina y su utilizacion en cosmetica.
WO2011065772A3 (en) Water in oil type cosmetic composition for improving skin
MX343326B (es) Metodos para mejorar el metabolismo energetico.
MX2010006987A (es) Composiciones topicas que contienen destiobiotin y sus derivados y un metodo de tratamiento para la piel.
UA95790C2 (ru) Применение неомыляемого экстракта растительной пульпы для лечения старения кожи
MX2010004814A (es) Metodos para tratar esclerodermia.
WO2021216687A9 (en) Peptides for the treatment of covid-19

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration